TY - JOUR
T1 - Acute effects of a novel inotropic agent, OPC-18790 (toborinone), on hemodynamics and myocardial energetics in patients with chronic heart failure
AU - Kanda, H.
AU - Yokota, M.
AU - Sobue, T.
AU - Ishihara, H.
AU - Nagata, K.
AU - Izawa, H.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1996
Y1 - 1996
N2 - We examined the acute effects and safety of OPC-18790 (toborinone), a novel water-soluble quinolinone derivative, on mechanoenergetics in 12 patients with chronic congestive heart failure. OPC-18790 was intravenously administered at a rate of 5 μg/kg/min or 10 μg/kg/min. Left ventricular (LV) pressure-volume data were obtained by conductance methods and myocardial oxygen consumption (MVO2) was measured using a Webster catheter. Heart rate was slightly increased in all patients after receiving OPC-18790. Ventricular preload as assessed by LV end-diastolic volume index significantly declined, and mean and systolic pulmonary artery pressure also fell after OPC-18790 infusion. In addition to venodilation, systemic vasodilation was observed after OPC-18790 infusion. Systolic and mean arterial pressure, and systemic vascular resistance significantly declined after OPC-18790 infusion. Effective arterial elastance (Ea), which represents both the mean vascular resistance and the pulsatile components, fell significantly. LV contractility as assessed by end-systolic elastance (Ees) significantly rose after OPC- 18790 infusion. Cardiac index and ejection fraction improved significantly. External work (EW) was unchanged. The isovolumic relaxation time constant was prolonged before OPC-18790 infusion and OPC-18790 shortened this time constant rate. MVO2 was reduced after OPC-18790 infusion probably due to a reduction of wall tension. Ventricular-arterial coupling (Ea/Ees) was far less than optimal before OPC-18790 infusion and was near optimal after OPC 18790 infusion. Mechanical efficiency (EW/MVO2) was improved along with the Ea/Ees ratio. Systolic arterial pressure fell by 40 or 50 mmHg after OPC- 18790 infusion in 2 patients probably due to vasodilation. In conclusion, OPC-18790 had favorable mechanoenergetic effects in patients with congestive heart failure. Despite enhancing contractility, OPC-18790 reduced MVO2 and improved mechanical efficiency probably due to its favorable effects on loading conditions. These findings suggest that OPC-18790 may be useful for short-term treatment of patients with congestive heart failure.
AB - We examined the acute effects and safety of OPC-18790 (toborinone), a novel water-soluble quinolinone derivative, on mechanoenergetics in 12 patients with chronic congestive heart failure. OPC-18790 was intravenously administered at a rate of 5 μg/kg/min or 10 μg/kg/min. Left ventricular (LV) pressure-volume data were obtained by conductance methods and myocardial oxygen consumption (MVO2) was measured using a Webster catheter. Heart rate was slightly increased in all patients after receiving OPC-18790. Ventricular preload as assessed by LV end-diastolic volume index significantly declined, and mean and systolic pulmonary artery pressure also fell after OPC-18790 infusion. In addition to venodilation, systemic vasodilation was observed after OPC-18790 infusion. Systolic and mean arterial pressure, and systemic vascular resistance significantly declined after OPC-18790 infusion. Effective arterial elastance (Ea), which represents both the mean vascular resistance and the pulsatile components, fell significantly. LV contractility as assessed by end-systolic elastance (Ees) significantly rose after OPC- 18790 infusion. Cardiac index and ejection fraction improved significantly. External work (EW) was unchanged. The isovolumic relaxation time constant was prolonged before OPC-18790 infusion and OPC-18790 shortened this time constant rate. MVO2 was reduced after OPC-18790 infusion probably due to a reduction of wall tension. Ventricular-arterial coupling (Ea/Ees) was far less than optimal before OPC-18790 infusion and was near optimal after OPC 18790 infusion. Mechanical efficiency (EW/MVO2) was improved along with the Ea/Ees ratio. Systolic arterial pressure fell by 40 or 50 mmHg after OPC- 18790 infusion in 2 patients probably due to vasodilation. In conclusion, OPC-18790 had favorable mechanoenergetic effects in patients with congestive heart failure. Despite enhancing contractility, OPC-18790 reduced MVO2 and improved mechanical efficiency probably due to its favorable effects on loading conditions. These findings suggest that OPC-18790 may be useful for short-term treatment of patients with congestive heart failure.
UR - http://www.scopus.com/inward/record.url?scp=0030445703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030445703&partnerID=8YFLogxK
U2 - 10.3999/jscpt.27.699
DO - 10.3999/jscpt.27.699
M3 - Article
AN - SCOPUS:0030445703
SN - 0388-1601
VL - 27
SP - 699
EP - 712
JO - Japanese Journal of Clinical Pharmacology and Therapeutics
JF - Japanese Journal of Clinical Pharmacology and Therapeutics
IS - 4
ER -